158 related articles for article (PubMed ID: 29483219)
1. Targeting PRPK Function Blocks Colon Cancer Metastasis.
Zykova T; Zhu F; Wang L; Li H; Lim DY; Yao K; Roh E; Yoon SP; Kim HG; Bae KB; Wen W; Shin SH; Nadas J; Li Y; Ma W; Bode AM; Dong Z
Mol Cancer Ther; 2018 May; 17(5):1101-1113. PubMed ID: 29483219
[TBL] [Abstract][Full Text] [Related]
2. The T-LAK Cell-originated Protein Kinase Signal Pathway Promotes Colorectal Cancer Metastasis.
Zykova TA; Zhu F; Wang L; Li H; Bai R; Lim DY; Yao K; Bode AM; Dong Z
EBioMedicine; 2017 Apr; 18():73-82. PubMed ID: 28412249
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of OX1 receptors for orexins in colon cancers and liver metastases: an openable gate to apoptosis.
Voisin T; El Firar A; Fasseu M; Rouyer-Fessard C; Descatoire V; Walker F; Paradis V; Bedossa P; Henin D; Lehy T; Laburthe M
Cancer Res; 2011 May; 71(9):3341-51. PubMed ID: 21415167
[TBL] [Abstract][Full Text] [Related]
4. Targeting PRPK and TOPK for skin cancer prevention and therapy.
Roh E; Lee MH; Zykova TA; Zhu F; Nadas J; Kim HG; Bae KB; Li Y; Cho YY; Curiel-Lewandrowski C; Einspahr J; Dickinson SE; Bode AM; Dong Z
Oncogene; 2018 Oct; 37(42):5633-5647. PubMed ID: 29904102
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of various biological parameters, including expression of survivin, between primary and metastatic human colonic adenocarcinomas.
Agui T; McConkey DJ; Tanigawa N
Anticancer Res; 2002; 22(3):1769-76. PubMed ID: 12168867
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the human PRPK-TPRKB complex.
Li J; Ma X; Banerjee S; Chen H; Ma W; Bode AM; Dong Z
Commun Biol; 2021 Feb; 4(1):167. PubMed ID: 33547416
[TBL] [Abstract][Full Text] [Related]
7. Expression of the antiapoptotic protein survivin in colon cancer.
Hernandez JM; Farma JM; Coppola D; Hakam A; Fulp WJ; Chen DT; Siegel EM; Yeatman TJ; Shibata D
Clin Colorectal Cancer; 2011 Sep; 10(3):188-93. PubMed ID: 21855041
[TBL] [Abstract][Full Text] [Related]
8. Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK.
Kang NJ; Lee KW; Kim BH; Bode AM; Lee HJ; Heo YS; Boardman L; Limburg P; Lee HJ; Dong Z
Carcinogenesis; 2011 Jun; 32(6):921-8. PubMed ID: 21317303
[TBL] [Abstract][Full Text] [Related]
9. MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signaling.
Uppada SB; Gowrikumar S; Ahmad R; Kumar B; Szeglin B; Chen X; Smith JJ; Batra SK; Singh AB; Dhawan P
Mol Cancer; 2018 Aug; 17(1):111. PubMed ID: 30068336
[TBL] [Abstract][Full Text] [Related]
10. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of TOPK at Y74, Y272 by Src increases the stability of TOPK and promotes tumorigenesis of colon.
Xiao J; Duan Q; Wang Z; Yan W; Sun H; Xue P; Fan X; Zeng X; Chen J; Shao C; Zhu F
Oncotarget; 2016 Apr; 7(17):24483-94. PubMed ID: 27016416
[TBL] [Abstract][Full Text] [Related]
12. Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer.
Ahn JY; Lee JS; Min HY; Lee HY
Oncotarget; 2015 Oct; 6(32):32622-33. PubMed ID: 26416450
[TBL] [Abstract][Full Text] [Related]
13. miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin.
Han J; Li J; Tang K; Zhang H; Guo B; Hou N; Huang C
Exp Cell Res; 2017 Nov; 360(2):328-336. PubMed ID: 28928082
[TBL] [Abstract][Full Text] [Related]
14. The importance of release of proinflammatory cytokines, ROS, and NO in different stages of colon carcinoma growth and metastasis after treatment with cytotoxic drugs.
Paduch R; Kandefer-Szerszeń M; Piersiak T
Oncol Res; 2010; 18(9):419-36. PubMed ID: 20524400
[TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of a p53-related protein kinase expressed in interleukin-2-activated cytotoxic T-cells, epithelial tumor cell lines, and the testes.
Abe Y; Matsumoto S; Wei S; Nezu K; Miyoshi A; Kito K; Ueda N; Shigemoto K; Hitsumoto Y; Nikawa J; Enomoto Y
J Biol Chem; 2001 Nov; 276(47):44003-11. PubMed ID: 11546806
[TBL] [Abstract][Full Text] [Related]
16. Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL.
Ravi R; Jain AJ; Schulick RD; Pham V; Prouser TS; Allen H; Mayer EG; Yu H; Pardoll DM; Ashkenazi A; Bedi A
Cancer Res; 2004 Dec; 64(24):9105-14. PubMed ID: 15604280
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
[TBL] [Abstract][Full Text] [Related]
18. RSK2 phosphorylates T-bet to attenuate colon cancer metastasis and growth.
Yao K; Peng C; Zhang Y; Zykova TA; Lee MH; Lee SY; Rao E; Chen H; Ryu J; Wang L; Zhang Y; Gao G; He W; Ma WY; Liu K; Bode AM; Dong Z; Li B; Dong Z
Proc Natl Acad Sci U S A; 2017 Nov; 114(48):12791-12796. PubMed ID: 29133416
[TBL] [Abstract][Full Text] [Related]
19. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.
Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I
Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730
[TBL] [Abstract][Full Text] [Related]
20. PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma.
Lei B; Qi W; Zhao Y; Li Y; Liu S; Xu X; Zhi C; Wan L; Shen H
Hum Pathol; 2015 Feb; 46(2):217-24. PubMed ID: 25466965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
